Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 83
  1. Dec 18, 2025 · 08:45 · CNVI

    Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

    Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

    01
  2. Dec 18, 2025 · 08:30 · AIAI

    NetraMark Delivers Transformational Quarter Of Execution

    NetraMark Delivers Transformational Quarter Of Execution

    02
  3. Dec 18, 2025 · 07:46 · MBX

    Microbix Reports Results for Q4 and Fiscal 2025

    Microbix Reports Results for Q4 and Fiscal 2025

    03
  4. Dec 18, 2025 · 07:31 · APLI

    Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

    Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

    04
  5. Dec 18, 2025 · 07:30 · BCT

    "Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine

    "Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine

    05
  6. Dec 18, 2025 · 07:30 · GUD

    Knight Therapeutics Announces Health Canada Approval for WYNZORA(TM) to Treat Psoriasis Vulgaris

    Knight Therapeutics Announces Health Canada Approval for WYNZORA(TM) to Treat Psoriasis Vulgaris

    06
  7. Dec 18, 2025 · 07:25 · KNE

    Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

    Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

    07
  8. Dec 18, 2025 · 07:03 · THRM

    Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

    Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

    08
  9. Dec 18, 2025 · 07:00 · NURS

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    09
  10. Dec 18, 2025 · 07:00 · VST

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

    10
  11. Dec 18, 2025 · 06:00 · 4875

    MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

    MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

    11
  12. Dec 17, 2025 · 21:19 · VPT

    Ventripoint to Issue Shares for Payment of Debenture Interest

    Ventripoint to Issue Shares for Payment of Debenture Interest

    12
  13. Dec 17, 2025 · 18:07 · UDOC

    Unidoc completes H3 Health Cube installation in Italy

    Unidoc completes H3 Health Cube installation in Italy

    13
  14. Dec 17, 2025 · 18:03 · LSL

    LSL Pharma to acquire Juno OTC for $5-million

    LSL Pharma to acquire Juno OTC for $5-million

    14
← Newer Older →